Moving into the second half of 2025, I am anticipating the reopening of the IPO market which is expected to gain momentum into early 2026.
Tech is the "canary in the coal mine" for orthopedics. Tech has shown us that the 2025 IPO market is open with some big successful IPOs like:
Circle Internet Group, Inc. (CRCL) at https://www.circle.com,
Chime Financial, Inc. (CHYM) at https://www.chime.com,
CoreWeave (CRWV) at https://www.coreweave.com,
SailPoint Technologies (SAIL) at https://www.sailpoint.com.
For growing orthopedic companies, the public markets present a unique opportunity to consider their financial exit strategies. A key tool for decision-making is the decision matrix, which evaluates two critical factors: growth rate (faster or slower than 25%) and profitability (projected to be profitable or unprofitable).
This article explores how orthopedic companies can leverage this matrix to determine the best exit strategy tailored to their financial health and market position.
The Decision Matrix
A decision matrix can help orthopedic companies assess their strategic options based on two axes:
Growth (%): Are you growing faster than 25% or slower than 25% annually?
Profitabi...
